Literature DB >> 2571865

Menstrual influence on surgical cure of breast cancer.

W J Hrushesky1, A Z Bluming, S A Gruber, R B Sothern.   

Abstract

In a retrospective study of 44 premenopausal women who underwent resection of a primary breast cancer and were followed for 5 to 12 years, disease recurrence and metastasis were more frequent and more rapid in women who had been operated upon during the perimenstrual period (days 0-6 and 21-36 of the menstrual cycle). By multivariate analysis, the time of resection in relation to the menstrual cycle is an independent predictor of the likelihood of future metastatic disease. Patients who underwent resection during the perimenstrual period had a more than quadrupled risk of recurrence and death compared with women operated upon during days 7 to 20 of the menstrual cycle.

Entities:  

Mesh:

Year:  1989        PMID: 2571865     DOI: 10.1016/s0140-6736(89)90956-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Timing of surgery during the menstrual cycle and prognosis of breast cancer.

Authors:  R A Badwe; I Mittra; R Havaldar
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

2.  Menstrual status and breast cancer surgery.

Authors:  Y Ville; S Lasry; F Spyratos; K Hacène; M Brunet
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

3.  The timing of breast cancer surgery within the menstrual cycle.

Authors:  A P Corder; M Cross; S A Julious; M A Mullee; I Taylor
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401

Review 4.  Does iron have a role in breast cancer?

Authors:  Xi Huang
Journal:  Lancet Oncol       Date:  2008-08       Impact factor: 41.316

Review 5.  Infections related to the menstrual cycle. A study of five otherwise healthy women with recurrent abscesses and a review of the literature.

Authors:  M Weischer; A Friis-Møller; A Bremmelgaard
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

6.  Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.

Authors:  Yong Zhu; Richard G Stevens; Derek Leaderer; Aaron Hoffman; Theodore Holford; Yawei Zhang; Heather N Brown; Tongzhang Zheng
Journal:  Breast Cancer Res Treat       Date:  2007-04-24       Impact factor: 4.872

7.  Estrous cycle modulates ovarian carcinoma growth.

Authors:  Guillermo N Armaiz-Pena; Lingegowda S Mangala; Whitney A Spannuth; Yvonne G Lin; Nicholas B Jennings; Alpa M Nick; Robert R Langley; Rosemarie Schmandt; Susan K Lutgendorf; Steven W Cole; Anil K Sood
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

Review 8.  Current management of carcinoma of the breast.

Authors:  T J Eberlein
Journal:  Ann Surg       Date:  1994-08       Impact factor: 12.969

9.  Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer.

Authors:  J Kurebayashi; H Sonoo; K Shimozuma
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

10.  Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients.

Authors:  W Jäger; W Sauerbrei
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.